Formulation Considerations for Autologous T Cell Drug Products

Formulation Considerations for Autologous T Cell Drug Products

Genetically modified autologous T cells have become an established immunotherapy in the fight against cancer. The manufacture of chimeric antigen receptor (CAR) and αβ-T cell receptor (TCR) transduced T cells poses unique challenges, including the formulation, cryopreservation and fill–finish steps,...

Full description

Bibliographic Details
Main Authors: Christopher F. van der Walle, Sonya Godbert, Gabriele Saito, Zein Azhari
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Pharmaceutics
Subjects:
closed process
fill–finish
design space
primary container
cryopreservation
freeze–thaw
Online Access:https://www.mdpi.com/1999-4923/13/8/1317

Internet

https://www.mdpi.com/1999-4923/13/8/1317

Similar Items